What are the NCCN treatment guidelines for locally advanced pancreatic cancer?

Updated: Mar 07, 2019
  • Author: Tomislav Dragovich, MD, PhD; Chief Editor: N Joseph Espat, MD, MS, FACS  more...
  • Print
Answer

NCCN treatment guidelines include the following recommendations [2] :

  • FOLFIRINOX or gemcitabine plus nab-paclitaxel is a first-line treatment for patients who have good performance status

  • Gemcitabine monotherapy, or palliative therapy and best supportive care, is recommended for locally advanced unresectable disease in symptomatic patients with poor performance status


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!